Age or age of onset: which is the best criterion to classify late-life depression?

IF 2.1 3区 医学 Q3 PHARMACOLOGY & PHARMACY International Clinical Psychopharmacology Pub Date : 2023-07-01 DOI:10.1097/YIC.0000000000000472
Paolo Olgiati, Giuseppe Fanelli, Alessandro Serretti
{"title":"Age or age of onset: which is the best criterion to classify late-life depression?","authors":"Paolo Olgiati,&nbsp;Giuseppe Fanelli,&nbsp;Alessandro Serretti","doi":"10.1097/YIC.0000000000000472","DOIUrl":null,"url":null,"abstract":"<p><p>In late-life depression (LLD), several differences between patients whose first episode is reported after age 65 (late-onset depression, LOD) and those with early-onset depression (EOD) might reflect the effects of brain ageing. To test this hypothesis, we analysed the impact of current age and age at illness onset on a number of clinical and cognitive manifestations in 438 outpatients with major depressive disorder aged >60 years, treated with venlafaxine for 12 weeks. When compared to the EOD group, patients with LOD were older ( P  < 0.00001) and associated with lower depression severity ( P  = 0.0029), lower global cognitive functioning [Mini-Mental State Examination (MMSE): P  = 0.0001; Repeatable Battery for the Assessment of Neuropsychological Status: immediate memory, P  = 0.0009, and delayed memory, P  < 0.00001; Delis-Kaplan Executive Function System measuring executive functions: Trail-Making Test (TMT) - P  = 0.0004 and Colour-Word Interference Test, Inhibition - P  = 0.0063], and more dyskinesias (Abnormal Involuntary Movement Scale: P  = 0.0006). After controlling for its interactions with age of onset, current age was inversely correlated with Montgomery Åsberg Depression Rating Scale scores at baseline ( P  < 0.00001) and week 12 ( P  = 0.0066), MMSE ( P  < 0.00001), delayed memory ( P  < 0.00001), and TMT ( P  = 0.0021). Age of onset predicted impairment in immediate ( P  = 0.023) and delayed memory ( P  = 0.0181), and dyskinesias ( P  = 0.0006). Although most features of LLD are related to ageing rather than to late-onset, LOD is a possible separate diagnostic entity characterised by memory dysfunction and increased liability to movement disorders.</p>","PeriodicalId":13698,"journal":{"name":"International Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234317/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/YIC.0000000000000472","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

In late-life depression (LLD), several differences between patients whose first episode is reported after age 65 (late-onset depression, LOD) and those with early-onset depression (EOD) might reflect the effects of brain ageing. To test this hypothesis, we analysed the impact of current age and age at illness onset on a number of clinical and cognitive manifestations in 438 outpatients with major depressive disorder aged >60 years, treated with venlafaxine for 12 weeks. When compared to the EOD group, patients with LOD were older ( P  < 0.00001) and associated with lower depression severity ( P  = 0.0029), lower global cognitive functioning [Mini-Mental State Examination (MMSE): P  = 0.0001; Repeatable Battery for the Assessment of Neuropsychological Status: immediate memory, P  = 0.0009, and delayed memory, P  < 0.00001; Delis-Kaplan Executive Function System measuring executive functions: Trail-Making Test (TMT) - P  = 0.0004 and Colour-Word Interference Test, Inhibition - P  = 0.0063], and more dyskinesias (Abnormal Involuntary Movement Scale: P  = 0.0006). After controlling for its interactions with age of onset, current age was inversely correlated with Montgomery Åsberg Depression Rating Scale scores at baseline ( P  < 0.00001) and week 12 ( P  = 0.0066), MMSE ( P  < 0.00001), delayed memory ( P  < 0.00001), and TMT ( P  = 0.0021). Age of onset predicted impairment in immediate ( P  = 0.023) and delayed memory ( P  = 0.0181), and dyskinesias ( P  = 0.0006). Although most features of LLD are related to ageing rather than to late-onset, LOD is a possible separate diagnostic entity characterised by memory dysfunction and increased liability to movement disorders.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
年龄或发病年龄:哪个是分类晚年抑郁症的最佳标准?
在晚年抑郁症(LLD)中,65岁以后报告首次发作的患者(迟发性抑郁症,LOD)和早发性抑郁症(EOD)之间的一些差异可能反映了大脑衰老的影响。为了验证这一假设,我们分析了438名年龄>60岁的重度抑郁症门诊患者的当前年龄和发病年龄对一些临床和认知表现的影响,这些患者接受文拉法辛治疗12周。与EOD组相比,LOD组患者年龄较大(P
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.40
自引率
23.10%
发文量
97
审稿时长
>12 weeks
期刊介绍: International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes. A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.
期刊最新文献
A comparative study of the efficacy of venlafaxine and naltrexone for relapse prevention in patients with opioid use disorder attributed to tramadol. UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients. Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder. Suicide in prison in the North of Italy (1993-2022): a case-control study examining differences between suicides inside and outside prison. Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1